- World rank, all time
- #33,626 of 34,923
- Rank in United Kingdom
- #1,799 of 1,844
- Research works
- 151 ▼ 70% vs 2018-21
- Citations
- 1.3k 8.4 per fractional work
- Top-10% rate
- 3.1% all institutions 10.0%
- vs its own fields
- 0.90× 1.00× is exactly expected
- Open access
- 43% world 40%
- International
- 43% world 18%
Which fields of science does BresMed work in?
In all years, 53% of research at BresMed is in Health Sciences, 30% in Social Sciences. Its largest fields are Medicine (50%), Economics, Econometrics and Finance (27%), Biochemistry, Genetics and Molecular Biology (6%). It does 2.2× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 23 fields, with their numbers
- Health Sciences8153.5%
- Medicine7549.8%
- Health Professions53.0%
- Nursing10.4%
- Dentistry00.2%
- Veterinary00.1%
- Social Sciences4630.3%
- Life Sciences1711.6%
- Physical Sciences74.6%
- Mathematics32.2%
- Engineering10.9%
- Materials Science10.4%
- Computer Science10.4%
- Environmental Science10.3%
- Earth and Planetary Sciences00.2%
- Physics and Astronomy00.1%
- Chemistry00.0%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 10.0×. Every wedge is a field page.
All 9 fields, with their numbers
- Economics, Econometrics and Finance10.02×3 works
- Immunology and Microbiology7.71×1 works
- Biochemistry, Genetics and Molecular Biology3.01×2 works
- Medicine2.44×7 works
- Mathematics1.41×0 works
- Health Professions1.12×0 works
- Business, Management and Accounting0.69×0 works
- Neuroscience0.34×0 works
- Social Sciences0.04×0 works
Who are the top researchers at BresMed?
Ranked on the quality score, Sarah C. Smith, Neil Roskell and Ronald R. Kidd lead among researchers whose main affiliation is BresMed.
- 1
Sarah C. Smith
United Kingdom · #1,368,132 worldwide 1.3k citations · 327 works
- 2
Neil Roskell
United Kingdom · #2,256,719 worldwide 1.4k citations · 43 works
- 3
Ronald R. Kidd
United Kingdom · #2,275,184 worldwide 65 citations · 45 works
- 4
Matthew Hemstock
United Kingdom · #2,326,654 worldwide 87 citations · 16 works
- 5
Ann-Marie Chapman
United Kingdom · #2,570,643 worldwide 320 citations · 26 works
- 6
Joshua K. Porter
United Kingdom · #2,840,335 worldwide 225 citations · 17 works
- 7
Marieke Schurer
United Kingdom · #2,961,471 worldwide 87 citations · 16 works
- 8
Owain Saunders
United Kingdom · #3,147,384 worldwide 444 citations · 19 works
- 9
Ash Bullement
United Kingdom · #3,150,195 worldwide 685 citations · 68 works
- 10
Elizabeth Thurgar
United Kingdom · #3,588,206 worldwide 163 citations · 29 works
Which keywords describe research at BresMed?
By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Pharmaceutical Industry, Clinical Trials, Drug Development Costs, Generic Drugs and Inflammation.
- Targeted Therapy
- Myelofibrosis
- JAK2 Mutation
- Immunogenicity
- Biosimilars
- PD-1 and PD-L1
- Pediatric Pharmacokinetics
- Drug Resistance
- Antiepileptic Drugs
- Rituximab
- Hypertension
- Lymphoma
- Tumor Microenvironment
- Diagnosis
- Financial Toxicity
- Immunotherapy
- Drug Development Costs
- Pharmaceutical Industry
- Inflammation
- Cost-effectiveness Analysis
- Quality of Life
- Health Utility Measures
- Clinical Trials
- Epidemiology
- Generic Drugs
- Cost of Care
- Genetics
- Classification
- Chemotherapy
- Cardiovascular Risk
- Prognostic Factors
- Minimal Residual Disease
- Medication Adherence
- Off-Label Drug Use
- Immune Checkpoint Blockade
- Prognostic Scoring System
- Diagnosis Criteria
- International Myeloma Working Group
- Monoclonal Antibodies
- PET Imaging
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Quality of Life25▲ 12×8 topics
- Cost-effectiveness Analysis23▲ 195×1 topic
- Health Utility Measures23▲ 195×1 topic
- Inflammation11▲ 3.0×17 topics
- Clinical Trials9▲ 9.6×11 topics
- Pharmaceutical Industry9▲ 149×2 topics
- Epidemiology9▲ 1.41×24 topics
- Drug Development Costs8▲ 204×1 topic
- Generic Drugs8▲ 204×1 topic
- Immunotherapy6▲ 5.7×7 topics
- Cost of Care5▲ 192×1 topic
- Financial Toxicity5▲ 192×1 topic
- Genetics5▲ 4.3×8 topics
- Diagnosis5▲ 3.0×13 topics
- Classification4▲ 8.1×2 topics
- Tumor Microenvironment4▲ 8.3×5 topics
- Chemotherapy4▲ 3.9×11 topics
- Lymphoma4▲ 18×2 topics
- Cardiovascular Risk4▲ 7.2×6 topics
- Hypertension3▲ 6.3×3 topics
- Prognostic Factors3▲ 5.0×8 topics
- Rituximab3▲ 14×3 topics
- Minimal Residual Disease3▲ 33×2 topics
- Antiepileptic Drugs3▲ 21×2 topics
- Medication Adherence3▲ 37×2 topics
- Drug Resistance3▲ 6.4×2 topics
- Off-Label Drug Use3▲ 55×1 topic
- Pediatric Pharmacokinetics3▲ 55×1 topic
- Immune Checkpoint Blockade3▲ 34×1 topic
- PD-1 and PD-L13▲ 34×1 topic
- Prognostic Scoring System3▲ 54×2 topics
- Biosimilars3▲ 122×1 topic
- Diagnosis Criteria3▲ 61×1 topic
- Immunogenicity3▲ 36×1 topic
- International Myeloma Working Group3▲ 61×1 topic
- JAK2 Mutation3▲ 88×1 topic
- Monoclonal Antibodies3▲ 13×2 topics
- Myelofibrosis3▲ 88×1 topic
- PET Imaging3▲ 8.4×4 topics
- Targeted Therapy3▲ 8.3×4 topics
Which research topics does BresMed publish most on?
By volume in 2022-now: Muscle Physiology and Disorders, Innovation Policy and R&D, Health Systems, Economic Evaluations, Quality of Life and Economic and Financial Impacts of Cancer.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Muscle Physiology and Disorders Molecular Biology 2 works
- 2 Innovation Policy and R&D Economics and Econometrics 1 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
- 4 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
- 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
- 6 Mast cells and histamine Immunology 1 works
- 7 Multiple Myeloma Research and Treatments Hematology 1 works
- 8 Viral-associated cancers and disorders Oncology 0 works
- 9 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 0 works
- 10 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has BresMed's research output changed?
Output in 2022-2025 was 70% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is BresMed as a percentage of every work published that year, 0.0000011% in 2024.
Fractional works of BresMed over all fractional works that year. How the balance of science has shifted.
Other research institutions in Sheffield
- University of Sheffield
- Sheffield Hallam University
- Sheffield Teaching Hospitals NHS Foundation Trust
- Sheffield City Council
- Sheffield Children's NHS Foundation Trust
- Sheffield Health and Social Care NHS Foundation Trust
- Knowledge Integration (United Kingdom)
- Insigneo
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about BresMed. Posts are plain text and can be reported.
